STA
MED icon

Summit Trail Advisors’s Medifast MED Stock Holding History

Summit Trail Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-553
Closed -$123K – 180
2018
Q3 		$123K Buy
553
+103
+23% +$20.9K 0.03% 246
2018
Q2 		$72K Buy
+450
New +$57.5K 0.03% 260
2018
Q1 		– Sell
-1,740
Closed -$125K – 1173
2017
Q4 		$125K Buy
+1,740
New +$115K 0.02% 565

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Summit Trail Advisors's MED Position: Q4 2018 in Review

Summit Trail Advisors sold out of Medifast (MED) in Q4 2018, closing a stake of 553 shares — an estimated $123K sold.

Summit Trail Advisors first reported a position in MED in Q4 2017 and held it in 3 quarters. The position peaked at $125K in Q4 2017. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

  • Summit Trail Advisors reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
  • Summit Trail Advisors sold 553 Medifast shares in Q4 2018, an estimated $123K.
  • Summit Trail Advisors first reported a position in Medifast in Q4 2017 and held it in 3 quarters.
  • Summit Trail Advisors's Medifast position peaked at $125K in Q4 2017.
  • 247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Summit Trail Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.